COCP stock news · Cocrystal Pharma, Inc.
Get alerts for COCP
Follow Cocrystal Pharma, Inc. (COCP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for COCPFree on the App Store and Google Play, or on the web.
Cocrystal Pharma shared its third quarter 2026 results, noting it finished dosing for its norovirus study.
NeutralCocrystal finished dosing its last norovirus-study participant. Quarterly research costs rose to $1.978 million from $954,000.